Novartis Eager to See More 1st Approvals in Japan despite Pricing Headache

Novartis Pharma President Dirk Kosche Novartis Pharma is committed to drug development in Japan and willing to seek the world’s first approval in the country for its new products despite challenges it might face on the pricing front, President Dirk...read more